{
    "clinical_study": {
        "@rank": "111203", 
        "brief_summary": {
            "textblock": "Studies of PEG-paclitaxel have been terminated"
        }, 
        "brief_title": "Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas", 
        "completion_date": "May 2002", 
        "condition": [
            "Neoplasm", 
            "Lymphomas", 
            "Neoplasm Metastasis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Lymphoma", 
                "Neoplasm Metastasis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "None - Study has been terminated."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "August 24, 2001", 
        "id_info": {
            "nct_id": "NCT00023166", 
            "org_study_id": "PTX-5001"
        }, 
        "intervention": {
            "intervention_name": "PEG-paclitaxel", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Paclitaxel"
        }, 
        "keyword": [
            "Phase I", 
            "Open label", 
            "Safety/efficacy", 
            "Lymphomas", 
            "Advanced primary and/or metastatic solid tumors", 
            "Neoplasms", 
            "Neoplasm metastasis"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "official_title": "Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors and Lymphomas", 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 1", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00023166"
        }, 
        "source": "Enzon Pharmaceuticals, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Enzon Pharmaceuticals, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2001", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2004"
    }, 
    "geocoordinates": {}
}